Related Experiment Video
Updated: Jun 23, 2026

07:01
An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
Published on: April 17, 2013
Autonomous thyroid adenoma: only an adulthood disease?
Karl Otfried Schwab1, Nicole Pfarr, Natascha van der Werf-Grohmann
1Department of Pediatrics and Adolescent Medicine, University Hospital, Freiburg, Germany. karl.otfried.schwab@uniklinikfreiburg.de
The Journal of Pediatrics
|May 19, 2009
Summary
Somatic activating mutations in the thyrotropin receptor gene and G-protein subunit were found in children with autonomous thyroid nodules. These genetic changes can lead to non-autoimmune hyperthyroidism in pediatric patients.
Area of Science:
- Endocrinology
- Genetics
- Pediatric Medicine
Background:
- Autonomous thyroid nodules (ATN) are common causes of hyperthyroidism.
- The genetic underpinnings of non-autoimmune hyperthyroidism in children are not fully understood.
- Thyrotropin receptor (TSHR) and G-protein signaling pathways are crucial in thyroid function.
Observation:
- Somatic activating mutations in the TSHR gene were identified in autonomous thyroid nodules (ATN) in two pediatric patients.
- A distinct pediatric patient presented with somatic activating mutations in the alpha-subunit of the stimulating G-protein within their ATN.
- These mutations were found within the nodules themselves, indicating a somatic origin.
Findings:
- The study identified specific somatic activating mutations within the thyrotropin receptor gene in pediatric patients with ATN.
- Activating mutations in the alpha-subunit of the stimulating G-protein were also observed in the ATN of another pediatric patient.
- These genetic alterations directly correlate with the development of hyperthyroidism.
Implications:
- Somatic activating mutations in TSHR and G-protein signaling are a significant cause of non-autoimmune hyperthyroidism in children.
- Understanding these genetic mechanisms can aid in diagnosing and potentially treating pediatric hyperthyroidism.
- This research highlights the role of somatic mutations in pediatric endocrine disorders.
Related Concept Videos
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Goiter
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
The Thyroid Gland
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...